Authors,Title,Year,Source title,Volume,Issue,Art. No.,Page start,Page end,Page count,Cited by,DOI,Link,Document Type,Source,EID
"Tran, T.D., Wakenhut, F., Pickford, C., Shaw, S., Westby, M., Smith-Burchnell, C., Watson, L., Paradowski, M., Milbank, J., Brimage, R.A., Halstead, R., Glen, R., Wilson, C.P., Adam, F., Hay, D., Chiva, J.-Y., Nichols, C., Blakemore, D.C., Gardner, I., Dayal, S., Pike, A., Webster, R., Pryde, D.C.","The discovery of potent nonstructural protein 5A (NS5A) inhibitors with a unique resistance profile - Part 1",2014,"ChemMedChem","9","7",,"1378","1386",,9,10.1002/cmdc.201400045,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84903819948&doi=10.1002%2fcmdc.201400045&partnerID=40&md5=7149f14fde4f6e9ab9acd89b76399308",Article,Scopus,2-s2.0-84903819948
"Wakenhut, F., Tran, T.D., Pickford, C., Shaw, S., Westby, M., Smith-Burchnell, C., Watson, L., Paradowski, M., Milbank, J., Stonehouse, D., Cheung, K., Wybrow, R., Daverio, F., Crook, S., Statham, K., Leese, D., Stead, D., Adam, F., Hay, D., Roberts, L.R., Chiva, J.-Y., Nichols, C., Blakemore, D.C., Goetz, G.H., Che, Y., Gardner, I., Dayal, S., Pike, A., Webster, R., Pryde, D.C.","The discovery of potent nonstructural protein 5A (NS5A) inhibitors with a unique resistance profile - Part 2",2014,"ChemMedChem","9","7",,"1387","1396",,9,10.1002/cmdc.201400046,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84903818637&doi=10.1002%2fcmdc.201400046&partnerID=40&md5=86afccb015549582d1857230f7c65b99",Article,Scopus,2-s2.0-84903818637
"Lavender, H., Brady, K., Burden, F., Delpuech-Adams, O., Denise, H., Palmer, A., Perkins, H., Savic, B., Scott, S., Smith-Burchnell, C., Troke, P., Wright, J.F., Suhy, D., Corbaua, R.","In vitro characterization of the activity of PF-05095808, a novel biological agent for hepatitis C virus therapy",2012,"Antimicrobial Agents and Chemotherapy","56","3",,"1364","1375",,10,10.1128/AAC.05357-11,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-84857153485&doi=10.1128%2fAAC.05357-11&partnerID=40&md5=8b88d013520194603d5799cbefee98ef",Article,Scopus,2-s2.0-84857153485
"Murray, E.J., Burden, F., Horscroft, N., Smith-Burchnell, C., Westby, M.","Knockdown of USP18 increases alpha 2a interferon signaling and induction of interferon-stimulating genes but does not increase antiviral activity in Huh7 cells",2011,"Antimicrobial Agents and Chemotherapy","55","9",,"4311","4319",,8,10.1128/AAC.00644-11,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-80051814230&doi=10.1128%2fAAC.00644-11&partnerID=40&md5=e589aa470278c7ae5bba5efb8af97e1a",Article,Scopus,2-s2.0-80051814230
"Corbau, R., Mori, J., Phillips, C., Fishburn, L., Martin, A., Mowbray, C., Panton, W., Smith-Burchnell, C., Thornberry, A., Ringrose, H., Knöchel, T., Irving, S., Westby, M., Wood, A., Perros, M.","Lersivirine, a nonnucleoside reverse transcriptase inhibitor with activity against drug-resistant human immunodeficiency virus type 1",2010,"Antimicrobial Agents and Chemotherapy","54","10",,"4451","4463",,47,10.1128/AAC.01455-09,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-77957370457&doi=10.1128%2fAAC.01455-09&partnerID=40&md5=5bd929d9a951c82841bb981097048081",Article,Scopus,2-s2.0-77957370457
"Westby, M., Smith-Burchnell, C., Mori, J., Lewis, M., Mosley, M., Stockdale, M., Dorr, P., Ciaramella, G., Perros, M.","Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry",2007,"Journal of Virology","81","5",,"2359","2371",,284,10.1128/JVI.02006-06,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-33847237614&doi=10.1128%2fJVI.02006-06&partnerID=40&md5=635241cc39b0883ff9e5893f127cc5a1",Article,Scopus,2-s2.0-33847237614
"Dorr, P., Westby, M., Dobbs, S., Griffin, P., Irvine, B., Macartney, M., Mori, J., Rickett, G., Smith-Burchnell, C., Napier, C., Webster, R., Armour, D., Price, D., Stammen, B., Wood, A., Perros, M.","Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity",2005,"Antimicrobial Agents and Chemotherapy","49","11",,"4721","4732",,724,10.1128/AAC.49.11.4721-4732.2005,"https://www.scopus.com/inward/record.uri?eid=2-s2.0-27644510382&doi=10.1128%2fAAC.49.11.4721-4732.2005&partnerID=40&md5=6cb47edb39d34ca9e57a7dfb2ccc4e16",Article,Scopus,2-s2.0-27644510382
